Applied Therapeutics Files 8-K on Financials

Applied Therapeutics, Inc. 8-K Filing Summary
FieldDetail
CompanyApplied Therapeutics, Inc.
Form Type8-K
Filed DateMay 13, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: financial-condition, results-of-operations, filing

Related Tickers: APLT

TL;DR

APLT filed an 8-K on 5/13/25 detailing financial results. Check it out.

AI Summary

Applied Therapeutics, Inc. filed an 8-K on May 13, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits, with the company's principal executive offices located at 545 Fifth Avenue, Suite 1400, New York, NY 10017. The company is incorporated in Delaware and operates in the Pharmaceutical Preparations sector.

Why It Matters

This 8-K filing provides investors with an update on Applied Therapeutics' financial performance and condition, which is crucial for assessing the company's stability and future prospects.

Risk Assessment

Risk Level: low — This filing is a routine disclosure of financial information and does not appear to contain any significant new risks or material adverse events.

Key Players & Entities

  • Applied Therapeutics, Inc. (company) — Registrant
  • May 13, 2025 (date) — Date of Report
  • 545 Fifth Avenue, Suite 1400, New York, NY 10017 (address) — Principal Executive Offices
  • Delaware (jurisdiction) — State of Incorporation

FAQ

What specific financial information is being reported in this 8-K filing?

The filing indicates it pertains to 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.

When was this 8-K report filed?

The report was filed on May 13, 2025.

Where are Applied Therapeutics, Inc.'s principal executive offices located?

The principal executive offices are located at 545 Fifth Avenue, Suite 1400, New York, NY 10017.

In which state is Applied Therapeutics, Inc. incorporated?

Applied Therapeutics, Inc. is incorporated in Delaware.

What is the Standard Industrial Classification (SIC) code for Applied Therapeutics, Inc.?

The SIC code is 2834, which corresponds to Pharmaceutical Preparations.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on May 13, 2025 regarding Applied Therapeutics, Inc..

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.